Tfo Tdc, LLC Amgen Inc Transaction History

Tfo Tdc, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $1.92 Million - $2.31 Million	-7,130 Reduced 99.93%	5 $1,000
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $1.78 Million - $2.01 Million	6,980 Added 4503.23%	7,135 $2.06 Million
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $34,320 - $41,830	152 Added 5066.67%	155 $37,000
Q4 2022 Feb 03, 2023	BUY	$229.03 - $291.01 $687 - $873	3 New	3 $0
Q2 2022 Jul 18, 2022	BUY	$230.71 - $256.74 $8,536 - $9,499	37 New	37 $9,000
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $7,429 - $8,704	-35 Closed	0 $0
Q2 2021 Jul 14, 2021	BUY	$233.58 - $259.14 $8,175 - $9,069	35 New	35 $8,000
Q3 2020 Oct 14, 2020	SELL	$234.65 - $260.95 $7,039 - $7,828	-30 Closed	0 $0
Q2 2020 Jul 17, 2020	BUY	$197.81 - $242.74 $5,934 - $7,282	30 New	30 $7,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

Stay updated on Tfo Tdc, LLC with notifications on news.